These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1919427)

  • 1. Influence of lovastatin therapy on metabolism of low density lipoproteins in mixed hyperlipidaemia.
    Vega GL; Grundy SM
    J Intern Med; 1991 Oct; 230(4):341-50. PubMed ID: 1919427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologic mechanisms of action of lovastatin in nephrotic syndrome.
    Aguilar-Salinas CA; Barrett PH; Kelber J; Delmez J; Schonfeld G
    J Lipid Res; 1995 Jan; 36(1):188-99. PubMed ID: 7706943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production.
    Arad Y; Ramakrishnan R; Ginsberg HN
    J Lipid Res; 1990 Apr; 31(4):567-82. PubMed ID: 2351867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lovastatin decreases de novo cholesterol synthesis and LDL Apo B-100 production rates in combined-hyperlipidemic males.
    Cuchel M; Schaefer EJ; Millar JS; Jones PJ; Dolnikowski GG; Vergani C; Lichtenstein AH
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):1910-7. PubMed ID: 9351353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lovastatin therapy in familial dysbetalipoproteinemia: effects on kinetics of apolipoprotein B.
    Vega GL; East C; Grundy SM
    Atherosclerosis; 1988 Mar; 70(1-2):131-43. PubMed ID: 3162680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pravastatin therapy in primary moderate hypercholesterolaemia: changes in metabolism of apolipoprotein B-containing lipoproteins.
    Vega GL; Krauss RM; Grundy SM
    J Intern Med; 1990 Feb; 227(2):81-94. PubMed ID: 2105373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercholesterolemia in postmenopausal women. Metabolic defects and response to low-dose lovastatin.
    Arca M; Vega GL; Grundy SM
    JAMA; 1994 Feb; 271(6):453-9. PubMed ID: 8295321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lovastatin therapy in nephrotic hyperlipidemia: effects on lipoprotein metabolism.
    Vega GL; Grundy SM
    Kidney Int; 1988 Jun; 33(6):1160-8. PubMed ID: 3165483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models.
    Krause BR; Newton RS
    Atherosclerosis; 1995 Oct; 117(2):237-44. PubMed ID: 8801869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.
    Ginsberg HN; Le NA; Gibson JC
    J Clin Invest; 1985 Feb; 75(2):614-23. PubMed ID: 3973021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-fold effect of lovastatin treatment on low density lipoprotein metabolism in subjects with hyperlipidemia: increase in receptor activity, decrease in apoB production, and decrease in particle affinity for the receptor. Results from a novel triple-tracer approach.
    Berglund L; Witztum JL; Galeano NF; Khouw AS; Ginsberg HN; Ramakrishnan R
    J Lipid Res; 1998 Apr; 39(4):913-24. PubMed ID: 9555954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships of plasma and hepatic variables with rates of plasma low-density lipoprotein apolipoprotein B metabolism in baboons fed low- and high-fat diets.
    Kushwaha RS; Barrett PH; Reardon CA; Lewis DS; Carey KD; Getz GS; McGill HC
    Metabolism; 1995 Aug; 44(8):1058-66. PubMed ID: 7637648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of lovastatin treatment on low-density lipoprotein hydrated density distribution and composition in patients with intermittent claudication and primary hypercholesterolemia.
    Tilly-Kiesi M
    Metabolism; 1991 Jun; 40(6):623-8. PubMed ID: 1865826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of low density lipoprotein apoprotein B metabolism by lovastatin and cholestyramine in miniature pigs: effects on LDL composition and synthesis of LDL subfractions.
    Huff MW; Telford DE
    Metabolism; 1989 Mar; 38(3):256-64. PubMed ID: 2918845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates.
    Forster LF; Stewart G; Bedford D; Stewart JP; Rogers E; Shepherd J; Packard CJ; Caslake MJ
    Atherosclerosis; 2002 Sep; 164(1):129-45. PubMed ID: 12119202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of lovastatin on concentrations and composition of lipoprotein subfractions.
    Nozaki S; Vega GL; Haddox RJ; Dolan ET; Grundy SM
    Atherosclerosis; 1990 Oct; 84(2-3):101-10. PubMed ID: 2282090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments.
    Lane DM; Alaupovic P; Knight-Gibson C; Dudley VS; Laughlin LO
    Am J Cardiol; 1995 Jun; 75(16):1124-9. PubMed ID: 7762498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability.
    Bredie SJ; de Bruin TW; Demacker PN; Kastelein JJ; Stalenhoef AF
    Am J Cardiol; 1995 Feb; 75(5):348-53. PubMed ID: 7856526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy and safety of fenofibrate and lovastatin in patients with primary type IIa or IIb hyperlipidaemia.
    Gholami K; Tavakoli N; Maleki M; Shafiee A
    J Clin Pharm Ther; 1998 Jun; 23(3):213-21. PubMed ID: 9831973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary fish oil plus lovastatin decreases both VLDL and LDL apo B production in miniature pigs.
    Huff MW; Telford DE; Barrett PH
    Arterioscler Thromb; 1992 Aug; 12(8):902-10. PubMed ID: 1637788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.